Prostate cancer
Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the bes...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Nelson, Adam W. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Latent variable mixture modelling and individual treatment prediction - Saunders, Rob ELSEVIER, 2019, Abingdon |
|---|---|
| Übergeordnetes Werk: |
volume:37 ; year:2019 ; number:9 ; pages:500-507 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.mpsur.2019.07.006 |
|---|
| Katalog-ID: |
ELV047956941 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV047956941 | ||
| 003 | DE-627 | ||
| 005 | 20230624142119.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191023s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mpsur.2019.07.006 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000752.pica |
| 035 | |a (DE-627)ELV047956941 | ||
| 035 | |a (ELSEVIER)S0263-9319(19)30161-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 150 |a 610 |q VZ |
| 084 | |a 77.20 |2 bkl | ||
| 084 | |a 77.75 |2 bkl | ||
| 084 | |a 44.91 |2 bkl | ||
| 100 | 1 | |a Nelson, Adam W. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prostate cancer |
| 264 | 1 | |c 2019 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available. | ||
| 650 | 7 | |a Men's health |2 Elsevier | |
| 650 | 7 | |a prostate cancer |2 Elsevier | |
| 650 | 7 | |a urology |2 Elsevier | |
| 650 | 7 | |a PSA |2 Elsevier | |
| 700 | 1 | |a Shah, Nimish |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Medicine Publishing Company |a Saunders, Rob ELSEVIER |t Latent variable mixture modelling and individual treatment prediction |d 2019 |g Abingdon |w (DE-627)ELV003386074 |
| 773 | 1 | 8 | |g volume:37 |g year:2019 |g number:9 |g pages:500-507 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.mpsur.2019.07.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 77.20 |j Behaviorismus |q VZ |
| 936 | b | k | |a 77.75 |j Verhaltenstherapie |q VZ |
| 936 | b | k | |a 44.91 |j Psychiatrie |j Psychopathologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 37 |j 2019 |e 9 |h 500-507 |g 8 | ||
| author_variant |
a w n aw awn |
|---|---|
| matchkey_str |
nelsonadamwshahnimish:2019----:rsae |
| hierarchy_sort_str |
2019 |
| bklnumber |
77.20 77.75 44.91 |
| publishDate |
2019 |
| allfields |
10.1016/j.mpsur.2019.07.006 doi GBV00000000000752.pica (DE-627)ELV047956941 (ELSEVIER)S0263-9319(19)30161-9 DE-627 ger DE-627 rakwb eng 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Nelson, Adam W. verfasserin aut Prostate cancer 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available. Men's health Elsevier prostate cancer Elsevier urology Elsevier PSA Elsevier Shah, Nimish oth Enthalten in Medicine Publishing Company Saunders, Rob ELSEVIER Latent variable mixture modelling and individual treatment prediction 2019 Abingdon (DE-627)ELV003386074 volume:37 year:2019 number:9 pages:500-507 extent:8 https://doi.org/10.1016/j.mpsur.2019.07.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 77.20 Behaviorismus VZ 77.75 Verhaltenstherapie VZ 44.91 Psychiatrie Psychopathologie VZ AR 37 2019 9 500-507 8 |
| spelling |
10.1016/j.mpsur.2019.07.006 doi GBV00000000000752.pica (DE-627)ELV047956941 (ELSEVIER)S0263-9319(19)30161-9 DE-627 ger DE-627 rakwb eng 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Nelson, Adam W. verfasserin aut Prostate cancer 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available. Men's health Elsevier prostate cancer Elsevier urology Elsevier PSA Elsevier Shah, Nimish oth Enthalten in Medicine Publishing Company Saunders, Rob ELSEVIER Latent variable mixture modelling and individual treatment prediction 2019 Abingdon (DE-627)ELV003386074 volume:37 year:2019 number:9 pages:500-507 extent:8 https://doi.org/10.1016/j.mpsur.2019.07.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 77.20 Behaviorismus VZ 77.75 Verhaltenstherapie VZ 44.91 Psychiatrie Psychopathologie VZ AR 37 2019 9 500-507 8 |
| allfields_unstemmed |
10.1016/j.mpsur.2019.07.006 doi GBV00000000000752.pica (DE-627)ELV047956941 (ELSEVIER)S0263-9319(19)30161-9 DE-627 ger DE-627 rakwb eng 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Nelson, Adam W. verfasserin aut Prostate cancer 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available. Men's health Elsevier prostate cancer Elsevier urology Elsevier PSA Elsevier Shah, Nimish oth Enthalten in Medicine Publishing Company Saunders, Rob ELSEVIER Latent variable mixture modelling and individual treatment prediction 2019 Abingdon (DE-627)ELV003386074 volume:37 year:2019 number:9 pages:500-507 extent:8 https://doi.org/10.1016/j.mpsur.2019.07.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 77.20 Behaviorismus VZ 77.75 Verhaltenstherapie VZ 44.91 Psychiatrie Psychopathologie VZ AR 37 2019 9 500-507 8 |
| allfieldsGer |
10.1016/j.mpsur.2019.07.006 doi GBV00000000000752.pica (DE-627)ELV047956941 (ELSEVIER)S0263-9319(19)30161-9 DE-627 ger DE-627 rakwb eng 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Nelson, Adam W. verfasserin aut Prostate cancer 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available. Men's health Elsevier prostate cancer Elsevier urology Elsevier PSA Elsevier Shah, Nimish oth Enthalten in Medicine Publishing Company Saunders, Rob ELSEVIER Latent variable mixture modelling and individual treatment prediction 2019 Abingdon (DE-627)ELV003386074 volume:37 year:2019 number:9 pages:500-507 extent:8 https://doi.org/10.1016/j.mpsur.2019.07.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 77.20 Behaviorismus VZ 77.75 Verhaltenstherapie VZ 44.91 Psychiatrie Psychopathologie VZ AR 37 2019 9 500-507 8 |
| allfieldsSound |
10.1016/j.mpsur.2019.07.006 doi GBV00000000000752.pica (DE-627)ELV047956941 (ELSEVIER)S0263-9319(19)30161-9 DE-627 ger DE-627 rakwb eng 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Nelson, Adam W. verfasserin aut Prostate cancer 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available. Men's health Elsevier prostate cancer Elsevier urology Elsevier PSA Elsevier Shah, Nimish oth Enthalten in Medicine Publishing Company Saunders, Rob ELSEVIER Latent variable mixture modelling and individual treatment prediction 2019 Abingdon (DE-627)ELV003386074 volume:37 year:2019 number:9 pages:500-507 extent:8 https://doi.org/10.1016/j.mpsur.2019.07.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 77.20 Behaviorismus VZ 77.75 Verhaltenstherapie VZ 44.91 Psychiatrie Psychopathologie VZ AR 37 2019 9 500-507 8 |
| language |
English |
| source |
Enthalten in Latent variable mixture modelling and individual treatment prediction Abingdon volume:37 year:2019 number:9 pages:500-507 extent:8 |
| sourceStr |
Enthalten in Latent variable mixture modelling and individual treatment prediction Abingdon volume:37 year:2019 number:9 pages:500-507 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Behaviorismus Verhaltenstherapie Psychiatrie Psychopathologie |
| institution |
findex.gbv.de |
| topic_facet |
Men's health prostate cancer urology PSA |
| dewey-raw |
150 |
| isfreeaccess_bool |
false |
| container_title |
Latent variable mixture modelling and individual treatment prediction |
| authorswithroles_txt_mv |
Nelson, Adam W. @@aut@@ Shah, Nimish @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV003386074 |
| dewey-sort |
3150 |
| id |
ELV047956941 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047956941</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142119.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.mpsur.2019.07.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000752.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047956941</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0263-9319(19)30161-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.91</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nelson, Adam W.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prostate cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Men's health</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">prostate cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">urology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PSA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shah, Nimish</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Medicine Publishing Company</subfield><subfield code="a">Saunders, Rob ELSEVIER</subfield><subfield code="t">Latent variable mixture modelling and individual treatment prediction</subfield><subfield code="d">2019</subfield><subfield code="g">Abingdon</subfield><subfield code="w">(DE-627)ELV003386074</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:500-507</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.mpsur.2019.07.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.20</subfield><subfield code="j">Behaviorismus</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.75</subfield><subfield code="j">Verhaltenstherapie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.91</subfield><subfield code="j">Psychiatrie</subfield><subfield code="j">Psychopathologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2019</subfield><subfield code="e">9</subfield><subfield code="h">500-507</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Nelson, Adam W. |
| spellingShingle |
Nelson, Adam W. ddc 150 bkl 77.20 bkl 77.75 bkl 44.91 Elsevier Men's health Elsevier prostate cancer Elsevier urology Elsevier PSA Prostate cancer |
| authorStr |
Nelson, Adam W. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV003386074 |
| format |
electronic Article |
| dewey-ones |
150 - Psychology 610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Prostate cancer Men's health Elsevier prostate cancer Elsevier urology Elsevier PSA Elsevier |
| topic |
ddc 150 bkl 77.20 bkl 77.75 bkl 44.91 Elsevier Men's health Elsevier prostate cancer Elsevier urology Elsevier PSA |
| topic_unstemmed |
ddc 150 bkl 77.20 bkl 77.75 bkl 44.91 Elsevier Men's health Elsevier prostate cancer Elsevier urology Elsevier PSA |
| topic_browse |
ddc 150 bkl 77.20 bkl 77.75 bkl 44.91 Elsevier Men's health Elsevier prostate cancer Elsevier urology Elsevier PSA |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
n s ns |
| hierarchy_parent_title |
Latent variable mixture modelling and individual treatment prediction |
| hierarchy_parent_id |
ELV003386074 |
| dewey-tens |
150 - Psychology 610 - Medicine & health |
| hierarchy_top_title |
Latent variable mixture modelling and individual treatment prediction |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV003386074 |
| title |
Prostate cancer |
| ctrlnum |
(DE-627)ELV047956941 (ELSEVIER)S0263-9319(19)30161-9 |
| title_full |
Prostate cancer |
| author_sort |
Nelson, Adam W. |
| journal |
Latent variable mixture modelling and individual treatment prediction |
| journalStr |
Latent variable mixture modelling and individual treatment prediction |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
100 - Philosophy & psychology 600 - Technology |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
500 |
| author_browse |
Nelson, Adam W. |
| container_volume |
37 |
| physical |
8 |
| class |
150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Nelson, Adam W. |
| doi_str_mv |
10.1016/j.mpsur.2019.07.006 |
| dewey-full |
150 610 |
| title_sort |
prostate cancer |
| title_auth |
Prostate cancer |
| abstract |
Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available. |
| abstractGer |
Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available. |
| abstract_unstemmed |
Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
9 |
| title_short |
Prostate cancer |
| url |
https://doi.org/10.1016/j.mpsur.2019.07.006 |
| remote_bool |
true |
| author2 |
Shah, Nimish |
| author2Str |
Shah, Nimish |
| ppnlink |
ELV003386074 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.mpsur.2019.07.006 |
| up_date |
2024-07-06T17:34:33.955Z |
| _version_ |
1803851948576735232 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047956941</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142119.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.mpsur.2019.07.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000752.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047956941</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0263-9319(19)30161-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.91</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nelson, Adam W.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prostate cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Prostate cancer is the most common male cancer in the UK. The disease and treatment options are wide ranging, from indolent disease requiring surveillance only to an aggressive malignancy requiring active treatment. This can prove to be challenging for both the doctor and patient deciding on the best management option. Ongoing research is revolutionizing the diagnostics, risk stratification and treatment of the disease. This article aims to summarize the current knowledge of prostate cancer and treatment options available.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Men's health</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">prostate cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">urology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PSA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shah, Nimish</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Medicine Publishing Company</subfield><subfield code="a">Saunders, Rob ELSEVIER</subfield><subfield code="t">Latent variable mixture modelling and individual treatment prediction</subfield><subfield code="d">2019</subfield><subfield code="g">Abingdon</subfield><subfield code="w">(DE-627)ELV003386074</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:500-507</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.mpsur.2019.07.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.20</subfield><subfield code="j">Behaviorismus</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.75</subfield><subfield code="j">Verhaltenstherapie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.91</subfield><subfield code="j">Psychiatrie</subfield><subfield code="j">Psychopathologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2019</subfield><subfield code="e">9</subfield><subfield code="h">500-507</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.3964148 |